Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220007736 220003067 1.64 null null null 2013-03-01 AML16 DA 3+10 Y N 220033038 AML16 TRIAL
220007737 220003067 1.69 106 Curative (C) 2013-04-30 2013-04-30 IDARUBICIN + TRETINOIN N N 220033038 IDARUBICIN + TRETINOIN
220007738 220003067 1.6 46.2 null 2015-11-13 2015-11-14 IDARUBICIN + TRETINOIN N N 220033038 IDARUBICIN + TRETINOIN
220007739 220003068 1.6 62 Curative (C) 2014-11-20 2014-11-20 AML18 PILOT TRIAL null null 220033041 PILOT TRIAL
220007740 220003068 1.84 null Disease modification (D) 2015-08-26 2015-08-26 AML 18 Pilot Trial 1 N 220033041 PILOT TRIAL
220007742 220003070 null 69.1 Disease modification (D) 2017-06-28 2017-06-28 AML 18 TRIAL 1 null 220033044 AML18 TRIAL
220007743 220011716 1.84 null Disease modification (D) 2016-06-22 2016-06-22 AML 18 Pilot Trial Y N 220033049 PILOT TRIAL
220007744 220003071 1.77 92.8 Disease modification (D) 2015-06-18 2015-06-18 Dasatinib N N 220033054 DASATINIB
220007745 220011717 1.88 97 Disease modification (D) null 2016-05-05 AML16 DA 3+10 N N 220033055 AML16 TRIAL
220007746 220011717 1.56 74.8 Curative (C) null 2017-12-07 IDARUBICIN + TRETINOIN 99 N 220033055 IDARUBICIN + TRETINOIN
220007747 220011717 null 97 Palliative (P) 2014-01-04 2014-01-18 GemCarbo Days 1+8 N null 220033055 GEMCARBO
220007748 220011717 null 57 Palliative (P) 2013-05-14 2013-05-29 GemCarbo Days 1+8 N null 220033055 GEMCARBO
220007749 220011717 1.67 65.7 Curative (C) 2013-04-03 2013-04-25 AML16 DA 3+10 02 N 220033055 AML16 TRIAL
220007750 220011717 null 123 Palliative (P) 2016-04-18 2016-04-25 GEMCARBO N N 220033055 GEMCARBO
220007751 220003072 null 54.4 Disease modification (D) 2017-02-04 2017-02-04 Dasatinib 02 N 220033067 DASATINIB
220007752 220003073 1.65 59.4 Curative (C) 2013-03-17 2013-03-17 IDARUBICIN + TRETINOIN N N 220033069 IDARUBICIN + TRETINOIN
220007753 220003074 1.88 90 null 2014-12-06 2014-12-06 Idarubicin+Tretinoin Spanish Crse1 2 N 220033073 IDARUBICIN + TRETINOIN
220007754 220003074 1.77 null Palliative (P) 2014-10-29 2014-11-12 CARBOPLATIN + GEMCITABINE null N 220033073 GEMCARBO
220007755 220003075 null null Curative (C) null 2013-09-25 AML18 PILOT TRIAL 1 N 220033075 PILOT TRIAL
220007756 220011719 1.73 64.5 Curative (C) 2013-10-02 2013-10-02 Idarubicin+Tretinoin Spanish Crse1 Y N 220033078 IDARUBICIN + TRETINOIN
220007757 220011719 1.69 72 Curative (C) 2013-08-25 2013-08-30 AML18 PILOT TRIAL Y N 220033078 PILOT TRIAL
220007758 220018930 1.69 81.3 Palliative (P) 2015-11-30 2016-01-16 Cisplatin+Gemcitabine (gallbladder) 2 N 220033081 CISPLATIN + GEMCITABINE
220007759 220003076 1.67 94.7 null 2013-10-09 2013-10-25 GEMCARBO 02 null 220033083 GEMCARBO
220007761 220003078 1.6 73.8 null 2013-05-24 2013-05-30 Cisplatin + Gemcitabine (D 1 & 8) N null 220033086 CISPLATIN + GEMCITABINE
220007762 220003079 1.73 59.7 null 2014-04-24 2014-05-08 GEMCARBO N N 220033087 GEMCARBO
220007763 220003079 1.51 null Curative (C) 2013-01-30 2013-02-20 AML 18 TRIAL 1 N 220033087 AML18 TRIAL
220007764 220003080 1.74 null Curative (C) 2014-03-11 2014-03-11 Idarubicin+Tretinoin Spanish Crse4 N N 220033090 IDARUBICIN + TRETINOIN
220007765 220003081 1.58 44.8 Curative (C) 2017-03-23 2017-04-01 Carboplatin + Paclitaxel (3 weekly) 02 N 220033093 CARBOPLATIN + PACLITAXEL
220007769 220016307 1.68 66.15 Palliative (P) 2017-07-04 2017-07-04 Cisplatin + Gemcitabine (D 1 & 8) null N 220033104 CISPLATIN + GEMCITABINE
220007770 220016307 1.83 52.7 null 2016-06-16 2016-06-23 GEMCARBO N N 220033104 GEMCARBO
220007771 220016307 1.82 78.1 Curative (C) 2014-04-07 2014-04-07 AML18 PILOT TRIAL N N 220033104 PILOT TRIAL
220007772 220016307 1.65 51 Palliative (P) 2013-07-09 2013-07-12 Dasatinib N N 220033104 DASATINIB
220007773 220003084 1.63 111.5 Disease modification (D) 2016-09-18 2016-09-28 AML16 DA 3+10 N N 220033114 AML16 TRIAL
220007774 220003084 1.61 82.1 Curative (C) null 2013-12-02 AML16 DA 3+8 N N 220033114 AML16 TRIAL
220007775 220003085 1.63 81 Curative (C) 2013-03-31 2013-03-31 IDARUBICIN + TRETINOIN null N 220033117 IDARUBICIN + TRETINOIN
220007776 220003086 1.85 69.3 Palliative (P) 2017-08-14 2017-08-16 AML16 DA 3+10 N N 220033121 AML16 TRIAL
220007777 220003087 1.85 86 Curative (C) 2016-07-29 2016-07-29 AML16 Low Dose Cytarabine 02 N 220033122 AML16 TRIAL
220007778 220003088 1.75 88.2 Curative (C) 2016-06-28 2016-07-10 AML 18 TRIAL 01 N 220033123 AML18 TRIAL
220007782 220003089 null 54 Curative (C) null 2013-06-13 AML 18 TRIAL Y null 220033130 AML18 TRIAL
220007783 220003090 1.63 114 Curative (C) 2017-05-13 2017-05-13 Idarubicin+Tretinoin Spanish Crse1 N N 220033132 IDARUBICIN + TRETINOIN
220007784 220003090 1.83 76 Curative (C) 2013-11-03 2013-11-03 AML18 PILOT TRIAL 1 N 220033132 PILOT TRIAL
220007785 220003090 null 74.7 Palliative (P) 2017-09-22 2017-11-02 Cisplatin+Gemcitabine (gallbladder) 02 N 220033132 CISPLATIN + GEMCITABINE
220007786 220003090 null null Curative (C) 2016-01-04 2016-01-05 AML18 PILOT TRIAL Y N 220033132 PILOT TRIAL
220007787 220003091 1.58 74.3 Curative (C) 2017-08-22 2017-08-26 AML18 PILOT TRIAL Y N 220033141 PILOT TRIAL
220007788 220003092 null 84 Curative (C) 2015-04-08 2015-04-08 AML 18 TRIAL 1 N 220033144 AML18 TRIAL
220007789 220003093 1.74 99.8 Palliative (P) 2017-10-20 2017-10-20 Cisplatin + Gemcitabine (D 1 & 8) N null 220033145 CISPLATIN + GEMCITABINE
220007790 220003094 1.87 79 null 2014-11-01 2014-11-01 Dasatinib 02 N 220033147 DASATINIB
220007791 220003095 1.67 113 null null 2013-02-14 AML16 DA 3+8 N N 220033149 AML16 TRIAL
220007795 220020442 null 69.5 Curative (C) 2016-06-28 2016-06-28 AML18 PILOT TRIAL N N 220033159 PILOT TRIAL
220007796 220020442 1.68 72.6 Adjuvant (A) 2017-09-11 2017-09-14 AML 18 TRIAL 1 N 220033159 AML18 TRIAL